Fulcrum Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Fulcrum Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2018 to Q3 2024.
  • Fulcrum Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 53.9M shares, a 3.53% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 53.9M +1.84M +3.53% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 62.3M +10.2M +19.5% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 62.1M +382K +0.62% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 61.9M +9.82M +18.8% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 52.1M +49.3K +0.1% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 52.1M +11.1M +27% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 61.8M +21.1M +51.8% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 52.1M +11.5M +28.2% Dec 31, 2022 10-K 2024-02-27
Q3 2022 52M +11.5M +28.4% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 41M +8.35M +25.6% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 40.7M +8.09M +24.8% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 40.6M +12.7M +45.4% Dec 31, 2021 10-K/A 2023-06-26
Q3 2021 40.5M +13.2M +48.6% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 32.7M +5.44M +20% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 32.6M +9.8M +43% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 27.9M +5.29M +23.3% Dec 31, 2020 10-K/A 2023-06-26
Q3 2020 27.3M +4.72M +20.9% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 27.2M +25.4M +1356% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 22.8M Mar 31, 2020 10-Q 2020-05-13
Q4 2019 22.7M +21.1M +1327% Dec 31, 2019 10-K/A 2023-06-23
Q3 2019 22.6M Sep 30, 2019 10-Q 2019-11-14
Q2 2019 1.87M Jun 30, 2019 10-Q 2019-08-26
Q4 2018 1.59M Dec 31, 2018 10-K 2020-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.